Page last updated: 2024-08-25

rosiglitazone and Pulmonary Disease, Chronic Obstructive

rosiglitazone has been researched along with Pulmonary Disease, Chronic Obstructive in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Feng, H; Kang, J; Yin, Y; Zheng, R1
Gross, N1
Fox, JC; Lea, S; Metcalfe, H; Plumb, J; Singh, D; Spicer, D; Woodman, P1
Duncan, SR; Lakshmi, SP; Mallampalli, RK; Reddy, AT; Reddy, RC; Sciurba, FC; Zhang, Y1
Morissette, MC; Shen, P; Stämpfli, MR; Thayaparan, D1
Dai, A; Hu, R; Li, J; Tan, S; Zhu, L1
Adinolfi, B; Bardelli, C; Betti, L; Breschi, MC; Brunelleschi, S; Fabbrini, L; Fogli, S; Giannaccini, G; Lucacchini, A; Mariotti, V; Melissari, E; Pellegrini, S; Stefanelli, F1
Bao, HR; Liao, JM; Liu, XJ; Tan, EL; Zeng, XL; Zhang, Y1

Other Studies

8 other study(ies) available for rosiglitazone and Pulmonary Disease, Chronic Obstructive

ArticleYear
Rosiglitazone ameliorated airway inflammation induced by cigarette smoke via inhibiting the M1 macrophage polarization by activating PPARγ and RXRα.
    International immunopharmacology, 2021, Volume: 97

    Topics: Animals; Cigarette Smoking; Disease Models, Animal; Humans; Lung; Macrophage Activation; Macrophages, Alveolar; Male; Nicotiana; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rosiglitazone; Smoke

2021
The COPD Pipeline XXI.
    COPD, 2013, Volume: 10, Issue:2

    Topics: Acetylcysteine; Clinical Trials as Topic; Cyclosporine; Drug Discovery; Humans; Orphan Drug Production; Pulmonary Disease, Chronic Obstructive; Research Design; Research Report; Rosiglitazone; Thiazolidinediones

2013
The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
    The European respiratory journal, 2014, Volume: 43, Issue:2

    Topics: Adrenal Cortex Hormones; Aged; Animals; Apoptosis; Chemokine CCL5; Dexamethasone; Female; Gene Expression Regulation; Humans; Hypoglycemic Agents; Inflammation; Interleukin-8; Ligands; Lipopolysaccharides; Macrophages; Macrophages, Alveolar; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neutrophils; Pioglitazone; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Rosiglitazone; Smoking; Thiazolidinediones; Tumor Necrosis Factor-alpha

2014
Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).
    The Journal of biological chemistry, 2014, Mar-07, Volume: 289, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Bronchi; Cells, Cultured; Down-Regulation; Drug Resistance; Gene Knockdown Techniques; Histone Deacetylase 2; Humans; Lung; NF-kappa B; Oleic Acids; Oxidative Stress; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Rosiglitazone; Smoking; Thiazolidinediones

2014
Impacts of peroxisome proliferator-activated receptor-γ activation on cigarette smoke-induced exacerbated response to bacteria.
    The European respiratory journal, 2015, Volume: 45, Issue:1

    Topics: Adrenal Cortex Hormones; Animals; Bacterial Infections; Bronchoalveolar Lavage Fluid; Dexamethasone; Female; Gene Expression Regulation, Bacterial; Lung; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Rosiglitazone; Smoking; Thiazolidinediones; Tobacco Products

2015
Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.
    Acta biochimica et biophysica Sinica, 2010, Volume: 42, Issue:9

    Topics: Aged; Animals; Blotting, Western; Female; Glutamate-Cysteine Ligase; Heat-Shock Proteins; Humans; Immunohistochemistry; In Situ Hybridization; Lipopolysaccharides; Lung; Male; Middle Aged; Nicotiana; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Rosiglitazone; Signal Transduction; Smoke; Thiazolidinediones; Transcription Factors

2010
Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle.
    British journal of pharmacology, 2011, Volume: 162, Issue:2

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthma; Carbachol; Cells, Cultured; Dexamethasone; Drug Tolerance; Guinea Pigs; Humans; In Vitro Techniques; Male; Muscle, Smooth; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Respiratory System; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Trachea

2011
[Effects of rosiglitazone on peroxisome proliferator activated receptor-γ pathway in patients with chronic obstructive pulmonary disease].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2011, Volume: 34, Issue:10

    Topics: Aged; Aged, 80 and over; Case-Control Studies; Cells, Cultured; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; NF-kappa B; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Rosiglitazone; Signal Transduction; Thiazolidinediones; Tumor Necrosis Factor-alpha; Up-Regulation

2011